September 1, 2010 – The European Society of Cardiology (ESC) upgraded fractional flow reserve (FFR) to a class I, level of evidence A, the highest class and level possible. The guidelines for FFR-guided treatment were included in the updated Guidelines on Percutaneous Coronary Intervention (PCI) announced Monday at the ESC congress in Stockholm.

September 1, 2010 – A new study on overall workforce trends in the field of cardiac electrophysiology (EP) reveals an increasing demand for EP professionals as a result of shifting demographic trends, evolving health reform policies and improved procedural outcomes.

September 1, 2010 – The first catheter to combine near-infrared (NIR) spectroscopy with intravascular ultrasound (IVUS) to characterize coronary plaque was cleared by the U.S. Food and Drug Administration (FDA).

September 1, 2010 - A new zotarolimus-eluting coronary stent using a biocompatible polymer gained CE mark and is being launched in Europe this week. The Medtronic Resolute Integrity Stent System features a novel drug-eluting coronary stent with good deliverability, the ability of the device to traverse the patient’s vasculature and reach the blockage in the heart artery.

September 1, 2010 - Z-Medica Corp., announced that it has signed an exclusive distribution agreement with Nihon-Kohden, Japan's manufacturer, developer and distributor of medical electronic equipment. The agreement allows Nihon-Kohden the exclusive right to distribute Z-Medica’s QuikClot line of hemostatic agents to hospital, military and law enforcement markets throughout Japan.

September 1, 2010 - The Certification Commission for Health Information Technology (CCHIT) in Chicago and the Drummond Group Inc.

August 30, 2010 - A system was released in Japan last week that helps guide treatment of cardiac arrhythmias by creating a 3-D cardiac map and model based on the information from electrophysiology (EP) catheters.

August 30, 2010 – According to the results of a late-breaking analysis involving more than 200 000 patients in recent clinical trials, antihypertensive treatments with renin-angiotensin system (RAS) inhibitors significantly differ in their ability to preserve lives.

August 30, 2010 – An enhanced version of the Philips iE33 xMatrix cardiac ultrasound system features a new ergonomic transducer for more efficient adult echocardiograms.

August 30, 2010 - Even though cardiac rehabilitation, a medically supervised program of services, can significantly improve the life expectancy and quality of life of people who have had a recent cardiac event, only one in five eligible patients actually receives this lifesaving and life-improving therapy.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now